Pregnancy in women with rare vascular diseases
A National Prospective Cohort for Pregnancies in Patients With Rare Vascular Anomalies: COGRare5 Study
This study is trying to learn about the pregnancy challenges faced by women with rare vascular diseases to help improve care for them and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 36 sites (Angers and 35 other locations) |
| Trial ID | NCT04194619 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on the obstetrical complications faced by women with rare vascular genetic disorders during pregnancy. It focuses on conditions such as Hereditary Hemorrhagic Telangiectasia, Marfan syndrome, and primary lower limb lymphedema. By collecting information through questionnaires, the study seeks to improve understanding and management of risks associated with these conditions in pregnant women. The ultimate goal is to formulate evidence-based recommendations to enhance maternal and fetal health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 45 who are currently pregnant or have given birth within the last month and have a diagnosis of a rare vascular disease.
Not a fit: Patients who do not meet the inclusion criteria or those under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies and reduced risks of complications during pregnancy for women with rare vascular diseases.
How similar studies have performed: While there is limited data on similar studies, the need for evidence-based recommendations indicates a gap in current research, suggesting this approach may be novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged ≥ 18 years and ≤45 years at the time of inclusion * Pregnant and/or having given birth less than 1 month (≤ 30 days) * Clinically and/or radiological and/or molecular biology diagnosis of a rare vascular disease before or during pregnancy or one month after delivery. * Having been informed of all pertinent aspects of the study and provided oral non-opposition. Exclusion Criteria: * Any person not fulfilling the inclusion criteria or refusing to take part in the study. * Major under legal protection
Where this trial is running
Angers and 35 other locations
- Service de Médecine Interne et Maladies Vasculaires + Service Neuropédiatrie et neurochirurgie de l'enfant - CHU Angers — Angers, France (Recruiting)
- Service de Médecine interne et immunologie clinique + Service de Médecine Vasculaire - Hôpital Saint André, CHU de Bordeaux — Bordeaux, France (Withdrawn)
- Service Pneumologie et Oncologie Thoracique - AP-HP Hôpital Ambroise Paré — Boulogne-Billancourt, France (Recruiting)
- Centre de Référence pour la maladie de Rendu-Osler - Service Génétique Clinique - Hôpital Femme-Mère-Enfant - Hospices Civils de Lyon — Bron, France (Recruiting)
- Service d'imagerie médicale - Neuroradiologie interventionnelle - Hôpital Neurologique P. Wertheimer - HCL — Bron, France (Withdrawn)
- Service d'Imagerie Pédiatrique et Fœtale et Consultation Pluridisciplinaire des Angiomes - Hôpital Femme-Mère-Enfant - HCL — Bron, France (Recruiting)
- Service de Génétique, Hôpital Femme-Mère-Enfant — Bron, France (Recruiting)
- Service de Médecine Vasculaire - Hôpital de la Côte de Nacre — Caen, France (Recruiting)
- Service Médecine Interne Estaing CHU de Clermont-Ferrand - Hôpital d'Estaing — Clermont-Ferrand, France (Recruiting)
- CHU Dijon Bourgogne - Hôpital François Mitterrand — Dijon, France (Recruiting)
- Service de Médecine vasculaire et HTA - Hôpital Albert Calmette, CHRU de Lille — Lille, France (Recruiting)
- Service Médecine interne - CHRU de Lille - Hôpital Claude Huriez — Lille, France (Recruiting)
- CHU de Marseille - Hôpital de la Timone — Marseille, France (Recruiting)
- Service Médecine Interne - Hôpital Saint-Eloi, CHU de Montpellier — Montpellier, France (Recruiting)
- Service de neuroradiologie diagnostique et interventionnelle - CHU de Nancy, Hôpital St-Julien — Nancy, France (Recruiting)
- Service de Médecine Interne-Médecine Vasculaire, CHU de Nantes - Hôtel Dieu — Nantes, France (Recruiting)
- Unité de neuro-interventionnelle CHU Nice, Hôpital Pasteur 2 — Nice, France (Recruiting)
- Service de dermatologie, CHU de Nice - Hôpital l'Archet 2 — Nice, France (Recruiting)
- Service de Neuroradiologie - AP-HP - Paris (Hôpital Lariboisière) — Paris, France (Recruiting)
- Service de Lymphologie - Hôpital Cognacq-Jay - Paris — Paris, France (Recruiting)
- Service de Cardiologie - Hôpital Bichat, AP-HP — Paris, France (Recruiting)
- Service de Neuroradiologie Interventionnelle - Fondation Adolphe de Rothschild — Paris, France (Recruiting)
- Service Radiologie-pneumologie interventionnelle - Hôpital Tenon AP-HP — Paris, France (Recruiting)
- Service de Génétique CHU de Poitiers — Poitiers, France (Recruiting)
- Service de Pneumologie CHU de Rennes - Hôpital Pontchaillou — Rennes, France (Recruiting)
- Unité de Génétique médicale, CHU de Rennes, Hôpital Sud — Rennes, France (Recruiting)
- Service Médecine Interne - Médecine vasculaire - CHU de Rouen, Hôpital Charles Nicolle — Rouen, France (Withdrawn)
- Service de Médecine Vasculaire et Thérapeutique, Explorations Fonctionnelles Vasculaires - CHU de Saint-Etienne - Hôpital Nord — Saint-Etienne, France (Recruiting)
- Clinique cardiologique et des maladies vasculaires CHU de Nantes, Hôpital G. R. LAENNEC — Saint-Herblain, France (Recruiting)
- Service Maladies vasculaires - HTA - NHC Pôle Médico-chirurgicale cardio-vasculaire, CHU de Strasbourg - Hôpital Civil — Strasbourg, France (Recruiting)
- CHU de Strasbourg, Hôpital de Hautepierre — Strasbourg, France (Recruiting)
- Service de Neuroradiologie Interventionnelle - Hôpital Foch — Suresnes, France (Recruiting)
- Service de Cardiologie _ Hôpital des Enfants (Purpan) — Toulouse, France (Recruiting)
- Service de Médecine Interne + Service Médecine Vasculaire _ Hôpital RANGUEIL — Toulouse, France (Recruiting)
- Service Pneumologie, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de TOURS — Tours, France (Recruiting)
- CHU de Nancy - Hôpitaux de Brabois — Vandœuvre-lès-Nancy, France (Withdrawn)
Study contacts
- Principal investigator: Sophie DUPUIS-GIROD, MD — Service de Génétique - Hôpital Femme-Mère-Enfant - HCL
- Study coordinator: Sophie DUPUIS-GIROD, MD
- Email: sophie.dupuis-girod@chu-lyon.fr
- Phone: 04 27 85 65 25
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.